Search

Search Constraints

You searched for: Author/Creator Shao, Ning

Search Results

3. Benefits of exenatide on obesity and non‐alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes. Issue 6 (September 2014)

7. Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway. (15th April 2018)